Cure GM1 funded pre-clinical studies, IND-enabling studies, and the Pre-IND briefing document for intravenous AAV9 GM1 gene therapy being conducted by investigators at UMass Medical School and Auburn University.
This project is being brought to human clinical trials in 2019. Please see the following for more information.